Incyte
INCY
#1178
Rank
A$27.63 B
Marketcap
A$138.86
Share price
1.73%
Change (1 day)
40.88%
Change (1 year)

Earnings for Incyte (INCY)

Earnings in 2025 (TTM): A$2.53 Billion

According to Incyte's latest financial reports the company's current earnings are A$5.14 Billion. , an increase over its 2024 earnings that were of A$0.45 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Incyte from 1994 to 2025

Annual earnings

Year Earnings Change
2025 A$2.40 B425.68%
2024 A$0.45 B-62.04%
2023 A$1.20 B57.66%
2022 A$0.76 B-7.24%
2021 A$0.82 B-345.65%
2020 -A$0.34 Billion-147.7%
2019 A$0.70 B322.02%
2018 A$0.16 B-136.94%
2017 -A$0.46 Billion-390.76%
2016 A$0.15 B1322%
2015 A$10.93 M-115.56%
2014 -A$70.28 Million-41.4%
2013 -A$0.12 Billion87.67%
2012 -A$63.91 Million-74.9%
2011 -A$0.26 Billion843.59%
2010 -A$26.98 Million-88.68%
2009 -A$0.24 Billion1.37%
2008 -A$0.24 Billion86.16%
2007 -A$0.13 Billion17.64%
2006 -A$0.11 Billion-28.62%
2005 -A$0.16 Billion-36.1%
2004 -A$0.24 Billion-2.03%
2003 -A$0.25 Billion22.26%
2002 -A$0.2 Billion-27.39%
2001 -A$0.28 Billion198.72%
2000 -A$90.6 Million132.2%
1999 -A$39.02 Million-556.86%
1998 A$8.54 M-37.23%
1997 A$13.6 M-259.32%
1996 -A$8.55 Million-45.87%
1995 -A$15.78 Million-9.17%
1994 -A$17.38 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
A$23.66 B 882.43%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$14.75 B 512.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$37.24 B 1,445.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$12.99 B 439.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$0.23 B-90.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
-A$66.48 Million-102.76%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-A$0.11 Billion-104.16%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
-A$42.04 Million-101.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-A$80.41 Million-103.34%๐Ÿ‡บ๐Ÿ‡ธ USA